Abstract:Background Alternol is a natural compound isolated from fermentation products of a mutant fungus. Our previous studies demonstrated that Alternol specifically kills cancer cells but spares benign cells. Methods To investigate the mechanism underlying alternol‐induced cancer cell‐specific killing effect, we took a comprehensive strategy to identify Alternol's protein targets in prostate cancer cells, including PC‐3, C4‐2, and 22RV1, plus benign BPH1 cell lines. Major experimental techniques included biotin‐streptavidin pulldown assay coupled with mass‐spectrometry, in vitro enzyme activity assay for Krebs cycle enzymes and gas chromatography‐mass spectrometry (GC‐MS) for metabolomic analysis. Results Among 14 verified protein targets, four were Krebs cycle enzymes, fumarate hydratase (FH), malate dehydrogenase‐2 (MDH2), dihydrolipoamide acetyltransferase (DLAT) in pyruvate dehydrogenase complex (PDHC) and dihydrolipoamide S‐succinyltransferase (DLST) in a‐ketoglutarate dehydrogenase complex (KGDHC). Functional assays revealed that PDHC and KGDHC activities at the basal level were significantly higher in prostate cancer cells compared to benign prostate BPH1 cells, while alternol treatment reduced their activities in cancer cells close to the levels in BPH1 cells. Although FH and MDH2 activities were comparable among prostate cancer and benign cell lines at the basal level, Alternol treatment largely increased their activities in cancer cells. Metabolomic analysis revealed that Alternol treatment remarkably reduced the levels of malic acid, fumaric acid, and isocitric acid and mitochondrial respiration in prostate cancer cells. Alternol also drastically reduced mitochondrial respiration and ATP production in PC‐3 cells in vitro or in xenograft tissues but not in BPH1 cells or host liver tissues. Conclusions Alternol interacts with multiple Krebs cycle enzymes, resulting in reduced mitochondrial respiration and ATP production in prostate cancer cells and xenograft tissues, providing a novel therapeutic strategy for prostate cancer treatment.

Retraction Note To: Alternol Inhibits Proliferation and Induces Apoptosis in Mouse Lymphocyte Leukemia (L1210) Cells.

Alternol Exerts Prostate‐selective Antitumor Effects Through Modulations of the AMPK Signaling Pathway

Alternol inhibits the proliferation and induces the differentiation of the mouse melanoma B16F0 cell line

Cell Growth Inhibition, G2M Cell Cycle Arrest, and Apoptosis Induced by the Novel Compound Alternol in Human Gastric Carcinoma Cell Line MGC803.

Natural compound Alternol exerts a broad anti-cancer spectrum and a superior therapeutic safety index in vivo

Natural compound Alternol actives multiple endoplasmic reticulum stress-responding pathways contributing to cell death

Linalool Inhibits the Growth of Human T Cell Acute Lymphoblastic Leukemia Cells with Involvement of the MAPK Signaling Pathway

Alternol Eliminates Excessive ATP Production by Disturbing Krebs Cycle in Prostate Cancer.

Alternol, a Natural Compound, Exerts an Anti‐tumour Effect on Osteosarcoma by Modulating of STAT3 and ROS/MAPK Signalling Pathways

Alternol Sensitizes Renal Carcinoma Cells to TRAIL-Induced Apoptosis

Lactobacillus metabolites induces apoptosis of human tongue squamous carcinoma cells

Alantolactone Induces Apoptosis and Cell Cycle Arrest on Lung Squamous Cancer Sk-Mes-1 Cells

Linalool Preferentially Induces Robust Apoptosis of a Variety of Leukemia Cells Via Upregulating P53 and Cyclin-Dependent Kinase Inhibitors

General toxicity and genotoxicity of alternariol: a novel 28-day multi-endpoint assessment in male Sprague–Dawley rats

Targeting non-oncogene ROS pathway by alantolactone in B cell acute lymphoblastic leukemia cells

Inhibitory Effects of Natural Compound Alantolactone on Human Non-small Cell Lung Cancer A549 Cells

Alantolactone induces apoptosis in chronic myelogenous leukemia sensitive or resistant to imatinib through NF-κB inhibition and Bcr/Abl protein deletion

Pro-Apoptotic Potential of Pseudevernia furfuracea (L.) Zopf Extract and Isolated Physodic Acid in Acute Lymphoblastic Leukemia Model In Vitro

Induction of Apoptosis in Human Promyelocytic Leukemia HL60 Cells by Panaxynol and Panaxydol.

Alternariol monomethyl ether toxicity and genotoxicity in male Sprague-Dawley rats: 28-Day in vivo multi-endpoint assessment

Bithionol eliminates acute myeloid leukaemia stem-like cells by suppressing NF-κB signalling and inducing oxidative stress, leading to apoptosis and ferroptosis